These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23746975)

  • 1. Modeling human disease with pluripotent stem cells: from genome association to function.
    Merkle FT; Eggan K
    Cell Stem Cell; 2013 Jun; 12(6):656-68. PubMed ID: 23746975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.
    George MN; Leavens KF; Gadue P
    Front Endocrinol (Lausanne); 2021; 12():682625. PubMed ID: 34149620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.
    Yu H; Cowan CA
    Mol Endocrinol; 2016 Jun; 30(6):575-86. PubMed ID: 27075706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing of human pluripotent stem cells to generate human cellular disease models.
    Musunuru K
    Dis Model Mech; 2013 Jul; 6(4):896-904. PubMed ID: 23751357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease models from pluripotent stem cells.
    Lengerke C; Daley GQ
    Ann N Y Acad Sci; 2009 Sep; 1176():191-6. PubMed ID: 19796247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene targeting of human pluripotent stem cells by homologous recombination.
    Howden SE; Thomson JA
    Methods Mol Biol; 2014; 1114():37-55. PubMed ID: 24557896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing in human pluripotent stem cells using site-specific nucleases.
    Chiba K; Hockemeyer D
    Methods Mol Biol; 2015; 1239():267-80. PubMed ID: 25408412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing precision medicine using scarless genome editing of human pluripotent stem cells.
    Steyer B; Cory E; Saha K
    Drug Discov Today Technol; 2018 Aug; 28():3-12. PubMed ID: 30205878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming neurodegeneration in the big data era.
    Zhou L; Verstreken P
    Curr Opin Neurobiol; 2018 Feb; 48():167-173. PubMed ID: 29331684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.
    Hitchler MJ; Rice JC
    Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells.
    Sato S; Yagi S; Arai Y; Hirabayashi K; Hattori N; Iwatani M; Okita K; Ohgane J; Tanaka S; Wakayama T; Yamanaka S; Shiota K
    Genes Cells; 2010 Jun; 15(6):607-18. PubMed ID: 20477876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important are rare variants in common disease?
    Saint Pierre A; Génin E
    Brief Funct Genomics; 2014 Sep; 13(5):353-61. PubMed ID: 25005607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and low-frequency variants in human common diseases and other complex traits.
    Lettre G
    J Med Genet; 2014 Nov; 51(11):705-14. PubMed ID: 25185437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From phenotypes to causal sequences: using genome wide association studies to dissect the sequence basis for variation of plant development.
    Ogura T; Busch W
    Curr Opin Plant Biol; 2015 Feb; 23():98-108. PubMed ID: 25449733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeled stem cells as disease models and in drug discovery.
    Ellerström C; Strehl R; Hyllner J
    Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.